Researchers find new mechanism to turn on cancer-killing T cells

A new mechanism involved in the anti-cancer immune response has been identified and may have implications for targeting antigens.

CXCL10: a promising marker for immunotherapy response in metastatic melanoma
New nanotechology design provides hope for personalized vaccination for treating cancer